Tech Company Financing Transactions

Sorbent Therapeutics Funding Round

AgeChem Venture Fund, Arch Venture Partners and Novartis Venture Fund participated in a $6.5 million Series D capital raise for Sorbent Therapeutics. The financing was announced on 5/15/2014.

Transaction Overview

Company Name
Sorbent Therapeutics
Announced On
5/15/2014
Transaction Type
Venture Equity
Amount
$6,500,000
Round
Series D
Investors

AgeChem Venture Fund (Nancy Hsiung)

Arch Venture Partners (Scott Minick)

Novartis Venture Fund (Markus Goebel)

Presidio Partners (David Collier)

Sofinnova Ventures (James Healy)

Proceeds Purpose
Proceeds from the financing will be used to support continued development of CLP-1001 and general corporate operations. Sorbent completed the enrollment of 275 patients with heart failure in its Phase 2b STEPWISE clinical trial of CLP-1001, a cross-linked polyelectrolyte polymer intended to selectively bind to and remove excess water and sodium in the GI tract.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
710 Lakeway Dr. 290
Sunnyvale, CA 94085
USA
Phone
(408) 738-8240
Website
www.sorbentrx.com
Email Address
[email protected]
Overview
Sorbent Therapeutics is a biopharmaceutical company focused on the development of adaptable non-absorbed polymeric drugs to satisfy unmet clinical needs in large markets such as End Stage Renal Disease (ESRD), Congestive Heart Failure (CHF), Chronic Kidney Disease (CKD), and Hypertension.
Profile
Sorbent Therapeutics LinkedIn Company Profile
Social Media
Sorbent Therapeutics Company Twitter Account
Company News
Sorbent Therapeutics News
Facebook
Sorbent Therapeutics on Facebook
YouTube
Sorbent Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Detlef Albrecht
  Detlef Albrecht LinkedIn Profile  Detlef Albrecht Twitter Account  Detlef Albrecht News  Detlef Albrecht on Facebook
Chief Financial Officer
Tom O'Neil
  Tom O'Neil LinkedIn Profile  Tom O'Neil Twitter Account  Tom O'Neil News  Tom O'Neil on Facebook
Chief Medical Officer
Howard Dittrich
  Howard Dittrich LinkedIn Profile  Howard Dittrich Twitter Account  Howard Dittrich News  Howard Dittrich on Facebook
VP - Bus. Development
Linda De Young
  Linda De Young LinkedIn Profile  Linda De Young Twitter Account  Linda De Young News  Linda De Young on Facebook

 

 

Browse more venture capital transactions:

Prev: 5/15/2014: Satago venture capital transaction
Next: 5/15/2014: Pantheon venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.